Chongqing Lummy Pharmaceutical announced that it has received the Drug Registration Certificate issued by the National Medical Products Administration for the 1 ml:0.4 mg specification of naloxone hydrochloride injection.
莱美药业：盐酸纳洛酮注射液获得药品注册证书
Chongqing Lummy Pharmaceutical: Naloxone Hydrochloride Injection obtained pharmaceutical registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.